FMDE 📈 Fidelity Covington Trust - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Mid-Cap Blend
FMDE: Stocks, Mid-Cap, Equities, US, Domestic, Foreign
The Fidelity Covington Trust, listed on the NYSE ARCA under the ticker FMDE, is an exchange-traded fund (ETF) that primarily focuses on investing in common stocks within the mid-cap segment of the U.S. equity market. Specifically, it aims to allocate at least 80% of its assets in stocks that are components of the Russell Midcap Index. This index is market capitalization-weighted, meaning that the stocks with the largest market capitalization have a greater influence on the index's performance. The Russell Midcap Index is designed to track the performance of the mid-cap segment of the U.S. equity market, which typically includes companies with market capitalizations between $2 billion and $10 billion.
The investment approach of the Fidelity Covington Trust is research-driven, where the adviser seeks to identify long-term drivers of stock returns. This involves analyzing various factors that can influence stock performance, including valuation, growth, quality, and other relevant metrics. By considering these factors, the adviser aims to construct a portfolio that can potentially outperform the broader mid-cap market over the long term. The fund's category is classified as Mid-Cap Blend, indicating that it seeks to balance value and growth investing within the mid-cap space, rather than focusing solely on one style. This blend approach can help in managing risk and potentially enhancing returns by diversifying across different investment styles.
As an ETF, the Fidelity Covington Trust offers investors the benefits of diversification, liquidity, and transparency. By tracking the Russell Midcap Index, the fund provides exposure to a broad range of mid-cap stocks, which can be an attractive option for investors looking to tap into the growth potential of mid-sized companies. The ETF structure also allows for flexibility in trading, as shares can be bought and sold throughout the trading day, similar to individual stocks. This can be particularly useful for investors who want to quickly adjust their portfolios in response to changing market conditions or investment strategies.
Additional Sources for FMDE ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FMDE ETF Overview
Market Cap in USD | 2,337m |
Category | Mid-Cap Blend |
TER | 0.23% |
IPO / Inception | 2007-12-20 |
FMDE ETF Ratings
Growth 5y | 75.6% |
Fundamental | - |
Dividend | 44.0% |
Rel. Strength Industry | 3.25 |
Analysts | - |
Fair Price Momentum | 33.77 USD |
Fair Price DCF | - |
FMDE Dividends
Dividend Yield 12m | 1.08% |
Yield on Cost 5y | 1.48% |
Annual Growth 5y | 275.19% |
Payout Consistency | 66.7% |
FMDE Growth Ratios
Growth Correlation 3m | 23.1% |
Growth Correlation 12m | 90% |
Growth Correlation 5y | 93.4% |
CAGR 5y | 31.47% |
CAGR/Mean DD 5y | 16.57 |
Sharpe Ratio 12m | 1.52 |
Alpha | 1.53 |
Beta | 1.00 |
Volatility | 14.61% |
Current Volume | 122k |
Average Volume 20d | 658.9k |
As of January 17, 2025, the stock is trading at USD 33.98 with a total of 122,026 shares traded.
Over the past week, the price has changed by +4.04%, over one month by -0.69%, over three months by +3.61% and over the past year by +27.02%.
Yes. Based on ValueRay Analyses, Fidelity Covington Trust (NYSE ARCA:FMDE) is currently (January 2025) a good stock to buy. It has a ValueRay Growth Rating of 75.62 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FMDE as of January 2025 is 33.77. This means that FMDE is currently overvalued and has a potential downside of -0.62%.
Fidelity Covington Trust has no consensus analysts rating.
According to ValueRays Forecast Model, FMDE Fidelity Covington Trust will be worth about 37.6 in January 2026. The stock is currently trading at 33.98. This means that the stock has a potential upside of +10.51%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 37.6 | 10.5% |